Opko Health, Inc.
OPK
$1.13
$0.021.35%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 581.12M | 606.88M | 642.07M | 664.03M | 689.41M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 581.12M | 606.88M | 642.07M | 664.03M | 689.41M |
| Cost of Revenue | 467.97M | 496.75M | 508.95M | 539.37M | 556.24M |
| Gross Profit | 113.15M | 110.13M | 133.11M | 124.66M | 133.17M |
| SG&A Expenses | 217.22M | 227.70M | 238.32M | 282.72M | 291.94M |
| Depreciation & Amortization | 77.00M | 77.89M | 79.18M | 80.08M | 81.06M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 788.66M | 830.56M | 854.67M | 930.39M | 957.46M |
| Operating Income | -207.54M | -223.69M | -212.61M | -266.37M | -268.05M |
| Income Before Tax | -228.97M | -241.39M | -159.50M | -152.51M | -578.00K |
| Income Tax Expenses | -16.05M | -15.71M | 20.89M | 24.62M | 38.42M |
| Earnings from Continuing Operations | -212.92 | -225.68 | -180.40 | -177.14 | -39.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -212.92M | -225.68M | -180.40M | -177.14M | -39.00M |
| EBIT | -207.54M | -223.69M | -212.61M | -266.37M | -268.05M |
| EBITDA | -117.19M | -132.06M | -119.32M | -171.65M | -172.21M |
| EPS Basic | -0.27 | -0.30 | -0.24 | -0.23 | -0.06 |
| Normalized Basic EPS | -0.27 | -0.29 | -0.11 | -0.17 | -0.05 |
| EPS Diluted | -0.27 | -0.30 | -0.24 | -0.24 | -0.07 |
| Normalized Diluted EPS | -0.27 | -0.29 | -0.15 | -0.17 | -0.06 |
| Average Basic Shares Outstanding | 3.09B | 3.00B | 2.91B | 2.83B | 2.74B |
| Average Diluted Shares Outstanding | 3.09B | 3.01B | 3.19B | 3.41B | 3.32B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |